Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Riemann P20 Once a Day sunfilter lotion SPF 50
130801000BBPAA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 2 |
|
Salicylic acid 2% / Sulfur 2% in Emulsifying ointment
1306010T0AAAQAQ
|
Sulfur (Topical) | Sulfur | Skin | 2 |
|
Salicylic acid 2% in White soft paraffin
1305020S0AACCCC
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 2 |
|
Salicylic acid 4% in Aqueous cream
1305020S0AADMDM
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 2 |
|
Salicylic acid 6% in Aqueous cream
1305020S0AADHDH
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 2 |
|
Skinsan 1% skin cleanser
1311050U0BQAAAI
|
Skinsan | Triclosan | Skin | 2 |
|
Sunsense anti-ageing face lotion SPF 50
130801000BBPCA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 2 |
|
The 50:50 Ointment
130201000BBJEA6
|
Proprietary compound emollients | Other emollient preparations | Skin | 2 |
|
Tretinoin 0.01% gel
1306010V0AAALAL
|
Tretinoin (Acne) | Tretinoin | Skin | 2 |
|
Tretinoin 0.025% cream
1306010V0AAAEAE
|
Tretinoin (Acne) | Tretinoin | Skin | 2 |
|
Triclosan 1% liquid
1311050U0AAAIAI
|
Triclosan (Topical) | Triclosan | Skin | 2 |
|
Wartex 50% ointment
1307000M0BIABAE
|
Wartex | Salicylic acid | Skin | 2 |
|
Zyomet 0.75% gel
1310012K0BIAAAR
|
Zyomet | Metronidazole | Skin | 2 |
|
Acnecide Face Wash 5% gel
1306010C0BUAEAB
|
Acnecide | Benzoyl peroxide | Skin | 1 |
|
Beclometasone 0.025% ointment 10% in White soft paraffin
1304000C0AACDCD
|
Beclometasone dipropionate (Topical) | Beclometasone dipropionate | Skin | 1 |
|
Benzoyl peroxide 10%/Potassium hydroxyquin sulf 0.5% crm
1306010C0AAATAT
|
Benzoyl peroxide | Benzoyl peroxide | Skin | 1 |
|
Betamethasone diprop 0.05% oint 5% in White soft paraffin
1304000D0AACCCC
|
Betamethasone esters | Betamethasone esters | Skin | 1 |
|
Betamethasone valerate 0.1% cream 10% in Aqueous cream
1304000F0AACPCP
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 1 |
|
Betamethasone valerate 0.1% oint 30% in White soft paraffin
1304000F0AADKDK
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 1 |
|
Betnovate-N cream
1304000F0BBALCB
|
Betnovate (Topical) | Betamethasone valerate | Skin | 1 |
|
ChloraPrep solution 10.5ml applicators
1311020L0CHADBY
|
ChloraPrep | Chlorhexidine gluconate | Skin | 1 |
|
ChloraPrep solution 26ml applicators
1311020L0CHAEBZ
|
ChloraPrep | Chlorhexidine gluconate | Skin | 1 |
|
ChloraPrep with Tint solution 10.5ml applicators
1311020L0CHAGBY
|
ChloraPrep | Chlorhexidine gluconate | Skin | 1 |
|
Chlorhexidine 0.5% / Isopropyl alcohol 70% impregnated swabs
1311010I0AAAFAF
|
Isopropyl alcohol (Topical) | Isopropyl alcohol | Skin | 1 |
|
Chlorhexidine acetate 0.02% irrig soln 1litre bottles
1311020G0AAAJAJ
|
Chlorhexidine acetate (Topical cleanser) | Chlorhexidine acetate | Skin | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.